Papp, Kim A, Joseph F Merola, Alice B Gottlieb, and Et al. “Dual Neutralization of IL-17A and IL-17F With Bimekizumab Improves Quality of Life in Patients Withmoderate-to-Severe Plaque Psoriasis: Results from a Phase 2b Study and Correlation With Clinical Response”. SKIN The Journal of Cutaneous Medicine 2 (December 17, 2018): S92. Accessed July 5, 2022. https://www.jofskin.org/index.php/skin/article/view/489.